Screener
Bio-Techne TECH EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Quarter Ended / March 31, 2026 | Quarter Ended / March 31, 2025 | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|---|---|
| Other comprehensive income (loss) | (4,512) | 3,598 | (6,976) | (3,736) |
| Comprehensive income | $46,535 | $26,186 | $120,265 | $87,342 |
| Earnings per share: | ||||
| Basic | $0.33 | $0.14 | $0.82 | $0.58 |
| Diluted | $0.32 | $0.14 | $0.81 | $0.57 |
| Weighted average common shares outstanding: | ||||
| Basic | 156,327 | 157,372 | 155,893 | 158,117 |
| Diluted | 157,403 | 158,944 | 156,943 | 160,662 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's EPS (diluted)?
- Bio-Techne (TECH) reported EPS (diluted) of $0.32 in Q1 2026.
- How has Bio-Techne's EPS (diluted) changed year-over-year?
- Bio-Techne's EPS (diluted) increased by 128.6% year-over-year, from $0.14 to $0.32.
- What is the long-term trend for Bio-Techne's EPS (diluted)?
- Over 2 years (2022 to 2024), Bio-Techne's EPS (diluted) has grown at a -40.1% compound annual growth rate (CAGR), from $2.93 to $1.05.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Bio-Techne's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude